BeOne Medicines
Sander van der Hiel currently serves as Commercial Director at BeiGene since January 2024. Prior to this role, Sander held various positions in the pharmaceutical industry, including Marketing Lead and National Sales Manager for Hematology at Bristol Myers Squibb from January 2021 to January 2024, and Product Manager for Hematology and Oncology at Celgene from May 2015 to January 2021. Sander's experience also includes being Sr Product Manager for Oncology at Teva Pharmaceuticals (May 2013 to May 2015), Brand Manager for Diabetes at Eli Lilly and Company (May 2011 to May 2013), and Sr Product Manager for Respiratory at AstraZeneca (October 2008 to January 2011). Early career roles at Wyeth Pharmaceuticals involved managing Oncology products, vaccines, and general managerial responsibilities. Sander holds a Master of Science in Business Administration and Management from Erasmus University Rotterdam.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.